This eBook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the eBook series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery
is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The fourth volume of this series features 5 chapters that cover the following topics:
- - An overview of the incidence of neuraminadase resistance in influenza viruses in the Americas from 2004 to 2014
- - Phenothiazines and derivative compounds for treating Trypanosoma cruzi infections
- - New antibacterial drug targets such as polysaccharide deacetylases
- - Improvements in aminoglycoside synthesis and biological activity (including RNA targeting)
- - A review of new chemotherapeutic agents against common infections.